drugset / Trial / NCT00018863

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

NCT00018863

RandomizedDouble-blindTreatment

Summary

This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).

Timeline

Start
2001-04-01
Primary completion
2006-03-31
Completion
2006-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 1.25 mg
Subject Methylphenidate Small molecule 2.5 mg
Subject Methylphenidate Small molecule 5 mg
Subject Methylphenidate Small molecule 7.5 mg